{"id":"https://openalex.org/W2964530478","doi":"https://doi.org/10.1111/jdi.13126","title":"Efficacy and safety of trelagliptin in Japanese patients with type 2 diabetes with severe renal impairment or end\u2010stage renal disease: Results from a randomized, phase 3 study","display_name":"Efficacy and safety of trelagliptin in Japanese patients with type 2 diabetes with severe renal impairment or end\u2010stage renal disease: Results from a randomized, phase 3 study","publication_year":2019,"publication_date":"2019-08-07","ids":{"openalex":"https://openalex.org/W2964530478","doi":"https://doi.org/10.1111/jdi.13126","mag":"2964530478","pmid":"https://pubmed.ncbi.nlm.nih.gov/31389201","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7078116"},"language":"en","primary_location":{"id":"doi:10.1111/jdi.13126","doi":"https://doi.org/10.1111/jdi.13126","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jdi.13126","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdi.13126","source":{"id":"https://openalex.org/S107365432","display_name":"Journal of Diabetes Investigation","issn_l":"2040-1116","issn":["2040-1116","2040-1124"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310322041","host_organization_name":"Asian Association for the Study of Diabetes","host_organization_lineage":["https://openalex.org/P4310322041"],"host_organization_lineage_names":["Asian Association for the Study of Diabetes"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Diabetes Investigation","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdi.13126","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036190568","display_name":"Kohei Kaku","orcid":"https://orcid.org/0000-0003-1574-0565","observed_orcids":["https://orcid.org/0000-0003-1574-0565"]},"institutions":[{"id":"https://openalex.org/I189996419","display_name":"Kawasaki Medical School","ror":"https://ror.org/059z11218","country_code":"JP","type":"education","lineage":["https://openalex.org/I189996419"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kohei Kaku","raw_affiliation_strings":["Department of Medicine, Kawasaki Medical School, Okayama, Japan"],"raw_orcid":"https://orcid.org/0000-0003-1574-0565","affiliations":[{"raw_affiliation_string":"Department of Medicine, Kawasaki Medical School, Okayama, Japan","institution_ids":["https://openalex.org/I189996419"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040688605","display_name":"Kazuyuki Ishida","orcid":"https://orcid.org/0000-0002-6347-126X","observed_orcids":["https://orcid.org/0000-0002-6347-126X"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuyuki Ishida","raw_affiliation_strings":["Takeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113867766","display_name":"Kohei Shimizu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kohei Shimizu","raw_affiliation_strings":["Takeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058531004","display_name":"Meguru Achira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Meguru Achira","raw_affiliation_strings":["Takeda PRA Development Center KK, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda PRA Development Center KK, Osaka, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044109406","display_name":"Yuusuke Umeda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuusuke Umeda","raw_affiliation_strings":["Takeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Development Center Japan, Takeda Pharmaceutical Company Limited, Osaka, Japan","institution_ids":["https://openalex.org/I44892455"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5036190568"],"corresponding_institution_ids":["https://openalex.org/I189996419"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":{"value":3500,"currency":"USD","value_usd":3500},"fwci":0.7906,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.77850155,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"11","issue":"2","first_page":"373","last_page":"381"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trelagliptin","display_name":"trelagliptin","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9319999814033508},{"id":"https://openalex.org/keywords/severe-renal-impairment","display_name":"severe renal impairment","score":0.9459999799728394},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":1.0},{"id":"https://openalex.org/keywords/hemodialysis","display_name":"hemodialysis","score":0.9800000190734863},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9049999713897705},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9160000085830688},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8809999823570251},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7289999723434448},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.6850000023841858}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9378990530967712},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6583220362663269},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.641130805015564},{"id":"https://openalex.org/C2778063415","wikidata":"https://www.wikidata.org/wiki/Q391744","display_name":"Hemodialysis","level":2,"score":0.5239282250404358},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5055851936340332},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.501401424407959},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4892451763153076},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.4777109622955322},{"id":"https://openalex.org/C3019040382","wikidata":"https://www.wikidata.org/wiki/Q476921","display_name":"End stage renal disease","level":3,"score":0.4633643329143524},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.46195247769355774},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4583761692047119},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.45496684312820435},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.45102283358573914},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.4451352059841156},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.41189032793045044},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3351612687110901},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.14484751224517822},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004035","descriptor_name":"Diet Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005081","descriptor_name":"Exercise Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044466","descriptor_name":"Asian People","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051437","descriptor_name":"Renal Insufficiency","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1111/jdi.13126","doi":"https://doi.org/10.1111/jdi.13126","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jdi.13126","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdi.13126","source":{"id":"https://openalex.org/S107365432","display_name":"Journal of Diabetes Investigation","issn_l":"2040-1116","issn":["2040-1116","2040-1124"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310322041","host_organization_name":"Asian Association for the Study of Diabetes","host_organization_lineage":["https://openalex.org/P4310322041"],"host_organization_lineage_names":["Asian Association for the Study of Diabetes"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Diabetes Investigation","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:6035678","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7078116","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:7078116","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7078116","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Diabetes Investig","raw_type":"Text"},{"id":"pmid:31389201","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31389201","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of diabetes investigation","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:doaj.org/article:938dabafc6de4fc0bd13629af2ba05e3","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/938dabafc6de4fc0bd13629af2ba05e3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Diabetes Investigation, Vol 11, Iss 2, Pp 373-381 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1111/jdi.13126","doi":"https://doi.org/10.1111/jdi.13126","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jdi.13126","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdi.13126","source":{"id":"https://openalex.org/S107365432","display_name":"Journal of Diabetes Investigation","issn_l":"2040-1116","issn":["2040-1116","2040-1124"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310322041","host_organization_name":"Asian Association for the Study of Diabetes","host_organization_lineage":["https://openalex.org/P4310322041"],"host_organization_lineage_names":["Asian Association for the Study of Diabetes"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Diabetes Investigation","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320310030","display_name":"Takeda Pharmaceuticals U.S.A.","ror":"https://ror.org/03bygaq51"},{"id":"https://openalex.org/F4320310465","display_name":"Takeda Pharmaceutical Company","ror":"https://ror.org/04hjbmv12"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2964530478.pdf","grobid_xml":"https://content.openalex.org/works/W2964530478.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1534249193","https://openalex.org/W1555274854","https://openalex.org/W1683243923","https://openalex.org/W1872244446","https://openalex.org/W1895049146","https://openalex.org/W1984774426","https://openalex.org/W2023749507","https://openalex.org/W2058178040","https://openalex.org/W2091422449","https://openalex.org/W2160180868","https://openalex.org/W2168577834","https://openalex.org/W2258701888","https://openalex.org/W2310493012","https://openalex.org/W2475101438","https://openalex.org/W2555586935","https://openalex.org/W2591361690","https://openalex.org/W2747127792","https://openalex.org/W2789732774","https://openalex.org/W2794676804","https://openalex.org/W4211190017"],"related_works":["https://openalex.org/W2807154678","https://openalex.org/W7098698445","https://openalex.org/W2258701888","https://openalex.org/W2100987099","https://openalex.org/W2045321591","https://openalex.org/W2162420953","https://openalex.org/W3000283549","https://openalex.org/W2075182875","https://openalex.org/W2609722039","https://openalex.org/W2154277743"],"abstract_inverted_index":{"INTRODUCTION:":[0],"To":[1],"investigate":[2],"the":[3,100,118,121,137,164,172,188,191,203,234],"efficacy":[4],"and":[5,66,130,139,175,200,205,231,236,252],"safety":[6,250],"of":[7,120,193,226],"trelagliptin":[8,82,98,161,242],"25":[9,243],"mg":[10,244],"in":[11,99,114,136,163,171,178,202,214,233,258],"patients":[12],"with":[13,18,52,247],"type":[14,48],"2":[15,49],"diabetes":[16,50],"mellitus":[17,51],"severe":[19,53,222],"renal":[20,24,54,62],"impairment":[21,55],"or":[22,60,87],"end-stage":[23,61],"disease.":[25],"MATERIALS":[26],"AND":[27],"METHODS:":[28],"This":[29],"multicenter,":[30],"randomized,":[31],"phase":[32,39,123],"3":[33],"study":[34],"comprised":[35],"a":[36,42,254],"12-week":[37],"double-blind":[38,93,122,189],"followed":[40],"by":[41],"40-week":[43],"open-label":[44,101],"phase.":[45,102],"Patients":[46,78],"had":[47],"(creatinine":[56],"clearance":[57],"<30":[58],"mL/min)":[59],"disease":[63],"(undergoing":[64],"hemodialysis),":[65],"were":[67,79,211],"receiving":[68],"diet":[69],"and/or":[70],"exercise":[71],"therapy":[72],"with/without":[73],"one":[74,215],"antidiabetic":[75],"drug.":[76],"RESULTS:":[77],"randomized":[80],"to":[81,167,184],"(A/A,":[83],"n":[84,90],"=":[85,91],"55)":[86],"placebo":[88],"(P/A,":[89],"52;":[92],"phase).":[94],"Both":[95],"groups":[96,180],"received":[97],"The":[103,224],"least":[104,144],"square":[105,145],"mean":[106],"change":[107],"(95%":[108,126,132],"confidence":[109],"interval":[110],"[CI])":[111],"from":[112],"baseline":[113,182],"hemoglobin":[115,157],"A1c":[116,158],"at":[117],"end":[119],"was":[124,198,229,245],"-0.71%":[125],"CI":[127,133,150],"-0.885,":[128],"-0.542)":[129],"0.01%":[131],"-0.170,":[134],"0.183)":[135],"A/A":[138,173,204,235],"P/A":[140,165,206,237],"groups,":[141],"respectively":[142],"(intergroup":[143],"means":[146],"difference":[147],"-0.72%,":[148],"95%":[149],"-0.966,":[151],"-0.473;":[152],"P":[153],"<":[154],"0.0001).":[155],"Mean":[156],"decreased":[159],"after":[160],"treatment":[162,256],"group":[166,174],"similar":[168],"levels":[169],"observed":[170],"remained":[176],"comparable":[177],"both":[179],"versus":[181],"up":[183],"week":[185],"52.":[186],"In":[187],"phase,":[190],"incidence":[192,225],"treatment-emergent":[194],"adverse":[195],"events":[196],"(TEAEs)":[197],"72.7%":[199],"61.5%":[201],"group,":[207,238],"respectively;":[208],"most":[209],"TEAEs":[210,228],"mild-to-moderate,":[212],"except":[213],"patient":[216,260],"(P/A":[217],"group),":[218],"who":[219],"experienced":[220],"two":[221],"TEAEs.":[223],"serious":[227],"7.3%":[230],"3.8%":[232],"respectively.":[239],"CONCLUSIONS:":[240],"Once-weekly":[241],"efficacious,":[246],"no":[248],"major":[249],"concerns,":[251],"represents":[253],"meaningful":[255],"option":[257],"this":[259],"population.":[261]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2019-08-13T00:00:00"}